Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting
- PMID: 23320165
- PMCID: PMC3539439
- DOI: 10.1155/2012/757152
Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting
Abstract
Objectives. We investigated IFN-γ levels before and after a six month course of isoniazid among individuals with latent tuberculosis infection (LTBI) in a high-transmission setting. Design. A total of 26 household contacts of pulmonary tuberculosis patients who were positive for LTBI by tuberculin skin test completed six months of treatment and submitted a blood sample for a follow-up examination. The IFN-γ response to Mycobacterium tuberculosis-specific antigens was measured, and the results before and after the completion of LTBI treatment were compared. Results. Of the 26 study participants, 25 (96%) showed an IFN-γ level higher than their baseline level before treatment (P ≤ 0.001). Only one individual had a decreased IFN-γ level after treatment but remained positive for LTBI. Conclusion. In a high-transmission setting, the IFN-γ level has increased after LTBI treatment. Further studies must be undertaken to understand if this elevation is transient.
Figures



Similar articles
-
Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.Br J Dermatol. 2013 Nov;169(5):1133-40. doi: 10.1111/bjd.12544. Br J Dermatol. 2013. PMID: 23909256
-
Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis.Lancet Infect Dis. 2020 Dec;20(12):1457-1469. doi: 10.1016/S1473-3099(20)30276-0. Epub 2020 Jul 13. Lancet Infect Dis. 2020. PMID: 32673595
-
Prevalence of latent tuberculosis infection in Sudan: a case-control study comparing interferon-γ release assay and tuberculin skin test.BMC Public Health. 2013 Dec 5;13:1128. doi: 10.1186/1471-2458-13-1128. BMC Public Health. 2013. PMID: 24313987 Free PMC article.
-
Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection.JAMA. 2001 Oct 10;286(14):1740-7. doi: 10.1001/jama.286.14.1740. JAMA. 2001. PMID: 11594899
-
[Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].Kekkaku. 2006 Nov;81(11):681-6. Kekkaku. 2006. PMID: 17154047 Review. Japanese.
Cited by
-
Advancement in diagnostic approaches for latent tuberculosis: distinguishing recent from remote infections.One Health Outlook. 2025 Apr 10;7(1):19. doi: 10.1186/s42522-025-00144-w. One Health Outlook. 2025. PMID: 40205610 Free PMC article. Review.
-
Capturing Recent Mycobacterium tuberculosis Infection by Tuberculin Skin Test vs. Interferon-Gamma Release Assay.Trop Med Infect Dis. 2024 Apr 11;9(4):81. doi: 10.3390/tropicalmed9040081. Trop Med Infect Dis. 2024. PMID: 38668542 Free PMC article.
-
Close contact interferon-gamma response to the new PstS1(285-374):CPF10: a preliminary 1-year follow-up study.BMC Res Notes. 2017 Jan 23;10(1):59. doi: 10.1186/s13104-016-2360-4. BMC Res Notes. 2017. PMID: 28114976 Free PMC article.
References
-
- Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. The Lancet. 2000;356(9235):1099–1104. - PubMed
-
- Pai M, Riley LW, Colford JM. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infectious Diseases. 2004;4(12):761–766. - PubMed
-
- Eum SY, Lee YJ, Kwak HK, et al. Evaluation of the diagnostic utility of a whole-blood interferon-γ assay for determining the risk of exposure to Mycobacterium tuberculosis in Bacille Calmette-Guerin (BCG)-vaccinated individuals. Diagnostic Microbiology and Infectious Disease. 2008;61(2):181–186. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources